120 related articles for article (PubMed ID: 6775094)
1. Oral medroxyprogesterone in the treatment of postmenopausal symptoms.
Schiff I; Tulchinsky D; Cramer D; Ryan KJ
JAMA; 1980 Sep; 244(13):1443-5. PubMed ID: 6775094
[TBL] [Abstract][Full Text] [Related]
2. Use of medroxyprogesterone acetate to prevent menopausal symptoms.
Bullock JL; Massey FM; Gambrell RD
Obstet Gynecol; 1975 Aug; 46(2):165-8. PubMed ID: 1153148
[TBL] [Abstract][Full Text] [Related]
3. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
[TBL] [Abstract][Full Text] [Related]
4. Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes.
Albrecht BH; Schiff I; Tulchinsky D; Ryan KJ
Am J Obstet Gynecol; 1981 Mar; 139(6):631-5. PubMed ID: 7211966
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal women without previous or current vasomotor symptoms do not flush after abruptly abandoning estrogen replacement therapy.
Hammar M; Ekblad S; Lönnberg B; Berg G; Lindgren R; Wyon Y
Maturitas; 1999 Jan; 31(2):117-22. PubMed ID: 10227004
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral medroxyprogesterone acetate on menopausal symptoms in patients with endometrial carcinoma.
Aslaksen K; Frankendal B
Acta Obstet Gynecol Scand; 1982; 61(5):423-8. PubMed ID: 6760653
[TBL] [Abstract][Full Text] [Related]
7. Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone.
Atala A; Amin M; Harty JI
Urology; 1992 Feb; 39(2):108-10. PubMed ID: 1736500
[TBL] [Abstract][Full Text] [Related]
8. Vasomotor symptoms, serum estrogens, and gonadotropin levels in surgical menopause.
Aksel S; Schomberg DW; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1976 Sep; 126(2):165-9. PubMed ID: 961757
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of the surgical menopause syndrome with depot medroxyprogesterone acetate and its objective evaluation testing the reaction of the anterior pituitary gland to stimulation with gonadotropin-releasing hormone].
Boschitsch E; Gitsch E; Spona J
Wien Klin Wochenschr; 1983 Oct; 95(20):718-24. PubMed ID: 6229096
[TBL] [Abstract][Full Text] [Related]
10. Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period.
Hagen C; Christensen MS; Christiansen C; Stocklund KE; Transbøl I
Acta Obstet Gynecol Scand; 1982; 61(3):237-41. PubMed ID: 6812385
[TBL] [Abstract][Full Text] [Related]
11. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
12. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
[TBL] [Abstract][Full Text] [Related]
14. Differences in the ratio of bioactive to immunoreactive serum luteinizing hormone during vasomotor flushes and hormonal therapy in postmenopausal women.
Chang SP; Shoupe D; Kletzky OA; Lobo RA
J Clin Endocrinol Metab; 1984 May; 58(5):925-9. PubMed ID: 6323519
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Irani J; Salomon L; Oba R; Bouchard P; Mottet N
Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
[TBL] [Abstract][Full Text] [Related]
16. The effect of estrogen-progestin treatment on opioid control of gonadotropin and prolactin secretion in postmenopausal women.
Dawood MY; Khan-Dawood FS; Ramos J
Am J Obstet Gynecol; 1986 Dec; 155(6):1246-51. PubMed ID: 3024488
[TBL] [Abstract][Full Text] [Related]
17. Veralipride: alternative antidopaminergic treatment for menopausal symptoms.
David A; Don R; Tajchner G; Weissglas L
Am J Obstet Gynecol; 1988 May; 158(5):1107-15. PubMed ID: 2967034
[TBL] [Abstract][Full Text] [Related]
18. Physiology and treatment of hot flushes.
Ravnikar V
Obstet Gynecol; 1990 Apr; 75(4 Suppl):3S-8S; discussion 15S-17S. PubMed ID: 2179788
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind cross-over trial into the effect of norethisterone on climacteric symptoms and biochemical profiles.
Paterson ME
Br J Obstet Gynaecol; 1982 Jun; 89(6):464-72. PubMed ID: 6805499
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with transcutaneous estradiol and oral medroxyprogesterone acetate.
Pedersen OD; Jensen HK
Acta Obstet Gynecol Scand; 1992 Dec; 71(8):593-8. PubMed ID: 1336917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
